US 9994547
Heteroarylamide inhibitors of TBK1
granted A61KA61K31/497A61P
Quick answer
US patent 9994547 (Heteroarylamide inhibitors of TBK1) held by Takeda Pharmaceutical Company Limited expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/497, A61P, A61P1/00, A61P13/00